• Strides receives USFDA approval for Ethacrynic Acid Tablets expresspharma
    October 22, 2020
    Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food & Drug Administration (USFDA).
PharmaSources Customer Service